Advanced search
Publication Cover
OncoTargets and Therapy Volume 6, 2013 - Issue
Submit an article Journal homepage
54
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?

Anas Gazzah1 SITEP (Service des Innovations Therapeutiques Précoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France
,
Daniel Barrios Gonzales1 SITEP (Service des Innovations Therapeutiques Précoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France
,
Antonin Levy1 SITEP (Service des Innovations Therapeutiques Précoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France
,
Rastislav Bahleda1 SITEP (Service des Innovations Therapeutiques Précoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France
,
Michel Ducreux2 Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France
,
Ludovic Lacroix3 Department of Biology, Institut Gustave Roussy, Paris XI University, Villejuif, France
&
Jean Charles Soria1 SITEP (Service des Innovations Therapeutiques Précoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, FranceCorrespondence[email protected]
 show all
Pages 95-97 | Published online: 20 Feb 2013

References

  • ConroyTDesseigneFYchouMFOLFIRINOX versus gemcitabine for metastatic pancreatic cancerN Engl J Med2011364191817182521561347
  • Garrido-LagunaITanACUsonMIntegrated preclinical and clinical development of mTOR inhibitors in pancreatic cancerBr J Cancer2010103564965520664591
  • JavleMMShroffRTXiongHInhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studiesBMC Cancer20101036820630061
  • WolpinBMHezelAFAbramsTOral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancerJ Clin Oncol200927219319819047305
  • CamidgeRPriceACharacterizing the phenomenon of radiation recall dermatitisRadiother Oncol200159323724511369064
  • BourgierCMassardCMoldovanCSoriaJCDeutschETotal recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect?Ann Oncol201122248548621278224
  • KlümpenHJQueirozKCSpekCAmTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndromeJ Clin Oncol2011296e150e15321189378
  • VoKAmarasingheBWashingtonKGonzalezABerlinJDangTPTargeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylationMol Cancer20111013822074495

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.